Gates Foundation

Portfolio Companies 2026 for Gates Foundation: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Gates Foundation accounts for 9 tracked companies with verified cap-table data, 9 of which disclose round sizes totalling $1.1B. The median disclosed raise is $125M, and the largest is Inovio Pharmaceuticals at $250M, ahead of Spero Therapeutics ($250M) and Lumen Bioscience ($185M).

The names that recur most often on these portfolio cap tables are Gates Foundation (9 companies), NIH (1 company), DARPA (1 company), CEPI (1 company), Atlas Venture (1 company), New Enterprise Associates (1 company). By latest disclosed round, the market skews Series A (3), Series C (2), Series E (1), Growth (1).

Best funded Gates Foundation companies

  1. Inovio Pharmaceuticals — $250M
  2. Spero Therapeutics — $250M (latest: Series A)
  3. Lumen Bioscience — $185M (latest: Series C)
  4. Owlstone Medical — $150M (latest: Series E)
  5. Manus Bio — $125M (latest: Growth)
  6. NILO Therapeutics — $101M (latest: Series A)
  7. Stellapps — $37M (latest: Series C)
  8. Ena Respiratory — $33M (latest: Series B)
  9. Micron Biomedical — $16M (latest: Series A)

Gates Foundation — related firms and companies (52)

Gates Foundation alternatives · All research reports